Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Apr 20, 2015Results Published in the Journal of American College of CardiologyToday the Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific Corporation (NYSE: BSX) S-ICD System™ (subcutaneous...
Apr 16, 2015Boston Scientific Corporation (NYSE: BSX) is taking a new approach to evaluate the performance of the Vessix™ Renal Denervation System, initiating a study with a novel design to isolate the...
Apr 14, 2015Companies Plan to Accelerate Physician Training and Expand Utilization of Less-Invasive Endoscopy Technologies in ChinaBoston Scientific Corporation (NYSE: BSX), a leading global medical device company, announced the signing of a strategic alliance with Frankenman Medical Equipment Company, a recognized leader...
- Apr 1, 2015
Boston Scientific Corporation (NYSE: BSX) announces that it has signed a definitive agreement to acquire Xlumena, Inc., a venture-backed medical device company that develops, manufactures and...
Apr 1, 2015Boston Scientific Corporation (NYSE: BSX) will webcast a conference call on Tuesday, April 28, 2015 at 8 a.m. ET to review financial results and business highlights for the first quarter 2015. The...
Mar 24, 2015Novel Stroke Risk Reduction Option for Indicated Patients with Atrial FibrillationThis week, four patients in the United States received the first implants of the Boston Scientific Corporation (NYSE: BSX) WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device. The WATCHMAN...
Mar 17, 2015Innovative device offers first-line treatment for patients at risk of sudden cardiac arrestBoston Scientific Corporation (NYSE: BSX) has received FDA and CE Mark approval of the EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) System. The EMBLEM S-ICD System is a treatment...
Mar 13, 2015First-Of-Its-Kind Alternative to Long-Term Warfarin Therapy for Stroke Risk Reduction in Patients with Non-Valvular Atrial FibrillationBoston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN Left Atrial Appendage Closure Device. The WATCHMAN Device offers a new...
Mar 3, 2015Boston Scientific Corporation (NYSE: BSX) announces the election of Charles J. Dockendorff and Stephen P. MacMillan to its board of directors, effective April 1, 2015. Two current members of the...
Mar 2, 2015Combined Business to Advance Patient Care with Leading Solutions Across Major Urology CategoriesBoston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Endo International plc (NASDAQ: ENDP) (TSX: ENL) to acquire the American Medical...
Feb 27, 2015Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Barclays 2015 Annual Healthcare Conference on March 10 in Miami Beach. Dan Brennan, executive vice president and chief...
Feb 26, 2015Boston Scientific Corporation (NYSE: BSX) announces 510(k) clearance and the first cases of the SpyGlass DS Direct Visualization System used for cholangioscopy and pancreatoscopy procedures. Built...
- Feb 25, 2015
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Cowen 35th Annual Healthcare Conference on March 4 in Boston. Dan Brennan, executive vice president and chief financial...
- Feb 17, 2015
Boston Scientific Corporation (NYSE: BSX) today announced the settlement of the breach of merger agreement lawsuit brought by Johnson & Johnson against Guidant Corporation, stemming from Boston...
- Feb 13, 2015
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the RBC Capital Markets 2015 Global Healthcare Conference on February 25 in New York City. Dan Brennan, executive vice...
- Feb 9, 2015
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Leerink 2015 Global Healthcare Conference on February 11 in New York City. Susan Lisa, vice president, Investor...
Feb 9, 2015Agreement Extends Reach of Lutonix DCB and Provides Physicians with a Comprehensive Solution to Prepare and Treat Diseased Femoropopliteal VesselsBoston Scientific Corporation (NYSE: BSX) and C. R. Bard, Inc. (NYSE: BCR) ("Bard") today announced that Boston Scientific will distribute the Lutonix® 035 Drug Coated Balloon Percutaneous...
- Feb 4, 2015
Boston Scientific Corporation (NYSE: BSX) generated sales of $1.887 billion during the fourth quarter ended December 31, 2014, compared to the company's guidance range for the quarter of $1.875 to...
Feb 3, 2015IndustryWeek recognition highlights manufacturing excellenceThe Boston Scientific (NYSE: BSX) Maple Grove Operations facility, Maple Grove, Minn., has been named a 2014 Best Plants winner by IndustryWeek magazine. IndustryWeek annually recognizes...
Feb 2, 2015Boston Scientific Corporation (NYSE: BSX) announces the launch and first U.S. implant of its line of Extended Longevity (EL) implantable cardioverter defibrillators (ICD), including DYNAGEN™ EL...
Jan 20, 2015Marlborough, Mass. (January 20, 2015) – Boston Scientific Corporation (NYSE: BSX), a global medical device company headquartered in Marlborough, Massachusetts, will co-sponsor the 2015...
Jan 15, 2015Boston Scientific Corporation (NYSE: BSX) will host and webcast an Investor Day business review meeting for the investment community on Friday, May 1, 2015. The meeting and webcast are scheduled...
- Jan 7, 2015
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year ended December 31, 2014 on...
-
Dec 22, 2014
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015 in San Francisco. Mike Mahoney, president...
-
Dec 18, 2014
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs CEOs Unscripted Healthcare Conference on Tuesday, January 6, 2015 in Boston. Mike Mahoney, president and...